MiR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells

Cancer Gene Therapy

Volumn 22, Issue 3, 2015, Pages 108-114

  Zhao, Z ^a   Zhang, L ^a   Yao, Q ^a   Tao, Z ^a  

^a FIRST AFFILIATED HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MICRORNA 15B; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIMENTIN; ANTINEOPLASTIC AGENT; MICRORNA; MIRN15 MICRORNA, HUMAN; PE-BINDING PROTEIN 4, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LUNG ADENOCARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SECONDARY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RNA INTERFERENCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84927691071     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2014.73     Document Type: Article

References (35)

1. Wang N, Liang H, Zhou Y, Wang C, Zhang S, Pan Y et al. miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. PLoS One 2014; 9: e105570.
2. Lee YH, Kim SY, Bae YS. Upregulation of miR-760 and miR-186 is associated with replicative senescence in human lung fibroblast cells. Mol Cells 2014; 37: 620-627.
3. Zhang Y, Yang Q, Wang S. MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol 2014; 74: 1105-1111.
4. Wu G, Ji Z, Li H, Lei Y, Jin X, Yu Y et al. Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements. Cell Biochem Funct 2014; 32: 547-556.
5. Kurioka D, Takeshita F, Tsuta K, Sakamoto H, Watanabe S, Matsumoto K et al. NEK9-dependent proliferation of cancer cells lacking functional p53. Sci Rep 2014; 4: 6111.
6. Li J, Wang Y, Song Y, Fu Z, Yu W. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Mol Cancer 2014; 13: 193.
7. Kim MK, Jung SB, Kim JS, Roh MS, Lee JH, Lee EH et al. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer. Virchows Arch 2014; 465: 463-471.
8. Zhong KZ, Chen WW, Hu XY, Jiang AL, Zhao J. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer. Int J Clin Exp Pathol 2014; 7: 4545-4551.
9. Zhong Z, Xia Y, Wang P, Liu B, Chen Y. Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer. Mol Med Rep 2014; 10: 2575-2579.
10. Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, Dave A et al. Small RNA combination therapy for lung cancer. Proc Natl Acad Sci USA 2014; 111: E3553-E3561.
11. Horie M, Saito A, Noguchi S, Yamaguchi Y, Ohshima M, Morishita Y et al. Differential knockdown of TGF ligands in a three-dimensional co-culture tumorstromal interaction model of lung cancer. BMC Cancer 2014; 14: 580.
12. Chen C, Chen J, Zhao KN. Editorial: Signalling pathways in anti-cancer drug resistance. Curr Med Chem 2014; 21: 3007-3008.
13. Gu Y, Cheng Y, Song Y, Zhang Z, Deng M, Wang C et al. MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1. PLoS One 2014; 9: e102602.
14. Zhao Y, Wei Q, Hu L, Chen FP, Hu Z, Heist RS et al. Polymorphisms in microRNAs are associated with survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2014; 23: 2503-2511.
15. Zhang X, Xiao D, Wang Z, Zou Y, Huang L, Lin W et al. MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis and prognosis by targeting CDC6 in lung cancer. Mol Cancer Res 2014; 12: 1535-1546.
16. Zhu W, Xu B. MicroRNA-21 identified as predictor of cancer outcome: a metaanalysis. PLoS One 2014; 9: e103373.
17. Loriot A, Van Tongelen A, Blanco J, Klaessens S, Cannuyer J, van Baren N et al. A novel cancer-germline transcript carrying pro-metastatic miR-105 and TETtargeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics 2014; 9: 1163-1171.
18. Won KJ, Im JY, Yun CO, Chung KS, Kim YJ, Lee JS et al. Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma. Int J Cancer 2014; 134: 2595-2604.
19. Nakadate Y, Kodera Y, Kitamura Y, Tachibana T, Tamura T, Koizumi F. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint. Biochem Biophys Res Commun 2013; 441: 793-798.
20. Ren XS, Yin MH, Zhang X, Wang Z, Feng SP, Wang GX et al. Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett 2014; 344: 195-203.
21. Fujita Y, Takeshita F, Kuwano K, Ochiya T. RNAi therapeutic platforms for lung diseases. Pharmaceuticals (Basel) 2013; 6: 223-250.
22. Fujita Y, Takeshita F, Mizutani T, Ohgi T, Kuwano K, Ochiya T. A novel platform to enable inhaled naked RNAi medicine for lung cancer. Sci Rep 2013; 3: 3325.
23. Zhang M, Luo W, Huang B, Liu Z, Sun L, Zhang Q et al. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression. PLoS One 2013; 8: e79173.
24. Takagi S, Oh-hara T, Sato S, Gong B, Takami M, Fujita N. Expression of Aggrus/ podoplanin in bladder cancer and its role in pulmonary metastasis. Int J Cancer 2014; 134: 2605-2614.
25. Morandell S, Reinhardt HC, Cannell IG, Kim JS, Ruf DM, Mitra T et al. A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo. Cell Rep 2013; 5: 868-877.
26. Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM et al. Collagen type XI -1 facilitates head and neck squamous cell cancer growth and invasion. Br J Cancer 2013; 109: 3049-3056.
27. Zhang T, Rong N, Chen J, Zou C, Jing H, Zhu X et al. SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC. PLoS One 2013; 8: e79162.
28. Banning A, Regenbrecht CR, Tikkanen R. Increased activity of mitogen activated protein kinase pathway in flotillin-2 knockout mouse model. Cell Signal 2014; 26: 198-207.
29. Tian H, Ge C, Li H, Zhao F, Hou H, Chen T et al. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma. Hepatology 2014; 59: 1459-1470.
30. Bailis JM, Gordon ML, Gurgel JL, Komor AC, Barton JK, Kirsch IR. An inducible, isogenic cancer cell line system for targeting the state of mismatch repair deficiency. PLoS One 2013; 8: e78726.
31. Hong SH, Minai-Tehrani A, Chang SH, Jiang HL, Lee S, Lee AY et al. Knockdown of the sodium-dependent phosphate co-transporter 2b (NPT2b) suppresses lung tumorigenesis. PLoS One 2013; 8: e77121.
32. Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB. STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells. Biomed Res Int 2013; 2013: 858946.
33. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW et al. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett 2014; 344: 20-27.
34. Lai CH, Park KS, Lee DH, Alberobello AT, Raffeld M, Pierobon M et al. HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. Oncogene 2013; 33: 4867-4876.
35. Rodríguez-Montes JA, Menéndez Sánchez P. Role of micro-RNA in colorectal cancer screening. Cir Esp 2014; 92: 654-658.